Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joep C Defesche

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
BMJ (Clinical Research Ed.)|November 13, 2008
Efficacy of statins in familial hypercholesterolaemia: a long term cohort studyJorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
European Journal of Human Genetics : EJHG|July 21, 2005
Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemiaEmily S van Aalst-Cohen, Angelique C M Jansen, S Matthijs Boekholdt, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2008
Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemiaKristel C M C Koeijvoets, Jeroen B van der Net, Elisabeth F C van Rossum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2005
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 productionJohn S Millar, Cyrille Maugeais, Katsunori Ikewaki, et al.
Circulation|March 9, 2011
Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic childrenAnouk van der Graaf, Hans J Avis, D Meeike Kusters, et al.
European Heart Journal|March 13, 2012
Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemiaMohammad Mahdi Motazacker, James Pirruccello, Roeland Huijgen, et al.
Atherosclerosis|September 20, 2011
Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortalityJorie Versmissen, Ilse P G Botden, Roeland Huijgen, et al.
European Heart Journal|December 23, 2008
Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemiaKristel C M C Koeijvoets, Simon P Mooijaart, Geesje M Dallinga-Thie, et al.
Diabetes Care|April 29, 2006
The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famineSusanne R de Rooij, Rebecca C Painter, David I W Phillips, et al.
The Lancet. Diabetes & Endocrinology|January 30, 2026
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trialAlbert Wiegman, Amy L Peterson, Eric Bruckert, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
BMJ (Clinical Research Ed.)|November 13, 2008
Efficacy of statins in familial hypercholesterolaemia: a long term cohort studyJorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
European Journal of Human Genetics : EJHG|July 21, 2005
Genetic determinants of plasma HDL-cholesterol levels in familial hypercholesterolemiaEmily S van Aalst-Cohen, Angelique C M Jansen, S Matthijs Boekholdt, et al.
The Journal of Clinical Endocrinology and Metabolism|September 25, 2008
Two common haplotypes of the glucocorticoid receptor gene are associated with increased susceptibility to cardiovascular disease in men with familial hypercholesterolemiaKristel C M C Koeijvoets, Jeroen B van der Net, Elisabeth F C van Rossum, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 8, 2005
Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 productionJohn S Millar, Cyrille Maugeais, Katsunori Ikewaki, et al.
Circulation|March 9, 2011
Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic childrenAnouk van der Graaf, Hans J Avis, D Meeike Kusters, et al.
European Heart Journal|March 13, 2012
Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemiaMohammad Mahdi Motazacker, James Pirruccello, Roeland Huijgen, et al.
Atherosclerosis|September 20, 2011
Maternal inheritance of familial hypercholesterolemia caused by the V408M low-density lipoprotein receptor mutation increases mortalityJorie Versmissen, Ilse P G Botden, Roeland Huijgen, et al.
European Heart Journal|December 23, 2008
Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemiaKristel C M C Koeijvoets, Simon P Mooijaart, Geesje M Dallinga-Thie, et al.
Diabetes Care|April 29, 2006
The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on glucose/insulin metabolism interact with prenatal exposure to famineSusanne R de Rooij, Rebecca C Painter, David I W Phillips, et al.
The Lancet. Diabetes & Endocrinology|January 30, 2026
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trialAlbert Wiegman, Amy L Peterson, Eric Bruckert, et al.
Pageof 10